Follikuláris limfóma: vizsgálatok itt: Hongkong

2 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  Where

  Hong Kong

  Életkor

  18 év to 130 év

  People

  1018 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06549595 · EU 2023-510098-33-01
• 2. fázisTaking people
  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Where

  Hong Kong, Shatin

  Életkor

  18 év and over

  People

  270 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06526793 · EU 2023-505789-27-00